• Leeds Beckett University Featured Masters Courses
  • Swansea University Featured Masters Courses
  • Xi’an Jiaotong-Liverpool University Featured Masters Courses
  • Imperial College London Featured Masters Courses
  • University of York Featured Masters Courses
  • Regent’s University London Featured Masters Courses
  • University of Edinburgh Featured Masters Courses
University of Birmingham Featured Masters Courses
Cardiff University Featured Masters Courses
University of Leeds Featured Masters Courses
University of Southampton Featured Masters Courses
Loughborough University Featured Masters Courses
"cancer" AND "pharmacolog…×
0 miles

Masters Degrees (Cancer Pharmacology)

  • "cancer" AND "pharmacology" ×
  • clear all
Showing 1 to 15 of 51
Order by 
This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. Read more
This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

The programme is designed to provide you with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and provides an expert view of the available cancer medicines and the development of new cancer therapies.

It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT, communication, and time management) and research techniques. The taught component of the course provides the in depth knowledge and skills necessary to work in cancer research, and is delivered across 2 semesters through lectures, workshops, practicals and 1-to-1 tutorials with ICT staff. You will then join one of our research teams to complete the MSc research project.

Why Bradford?

-The course is hosted by the Institute of Cancer Therapeutics, which has an international reputation as a centre of excellence in Cancer Pharmacology
-It benefits from the multidisciplinary team of researchers in the field of anti-cancer drug design, synthesis, screening and pharmacology both at the University and through our extensive links with experts at other universities and industry
-You will also benefit from working in excellent research laboratories in a research-focused environment

Modules

-Molecular Basis of Cancer and Cancer Therapy
-Preclinical Models for Drug Evaluation
-Cancer Pharmacology
-Experimental Design
-Research and Analytical Methods
-Critical Appraisal of a Current Topic in Cancer Pharmacology
-Research Project (ICT)

Career support and prospects

The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.

Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.

Many students go on to study for PhDs either at Bradford or elsewhere. Recent graduates are studying at Dundee, Newcastle and Glasgow universities, and at medical schools in the UK and abroad.

Those in employment are in R&D, clinical research and teaching roles.

Read less
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work. Read more
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of this course are to:
-Provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving;
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease;
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data;
deliver a programme of advanced study to equip you for a future career in anti-cancer drug development.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Medical Genetics (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)
-Advanced Drug Formulation Technologies (option, 20 credits)
-Bioinformatics and Molecular Modelling (option, 20 credits)
-Drug Discovery Technology (option, 20 credits)

After the course

This course is primarily designed for those wishing to pursue a career in anti-cancer drug development, whether in academia or within the pharmaceutical industry. The programme provides an excellent basis for further research or study.

Moving to one campus

Between 2016 and 2020 we're investing £125 million in the London Metropolitan University campus, moving all of our activity to our current Holloway campus in Islington, north London. This will mean the teaching location of some courses will change over time.

Whether you will be affected will depend on the duration of your course, when you start and your mode of study. The earliest moves affecting new students will be in September 2017. This may mean you begin your course at one location, but over the duration of the course you are relocated to one of our other campuses. Our intention is that no full-time student will change campus more than once during a course of typical duration.

All students will benefit from our move to one campus, which will allow us to develop state-of-the-art facilities, flexible teaching areas and stunning social spaces.

Read less
This programme gives you in-depth knowledge of the scientific basis of drug discovery and development, which has revolutionised the pharmaceutical industry in recent years. Read more
This programme gives you in-depth knowledge of the scientific basis of drug discovery and development, which has revolutionised the pharmaceutical industry in recent years. Our involvement with international drug companies has allowed us to keep our courses fully up-to-date. With our excellent facilities, emphasis on practical work, and teaching underpinned by the latest research, you will be qualified for research and development positions in pharmaceutical companies, as well as a wide range of other roles in industry.

About the course

The programme will have a heavy emphasis on practical work and will cover the following areas:
-Pharmacological and relevant physiological principles
-Molecular biology techniques in pharmacology
-The application of bioinformatics to drug discovery
-Quantitative aspects of pharmacology
-Case studies in drug discovery
-Molecular medicine
-Neuro-degenerative diseases
-Safety evaluationResearch project

You will undertake a practical project as part of your MSc enabling you to use our excellent facilities and to gain experience working alongside researchers in our Pharmacology Research Group. Current research projects include studies in:
-Gastrointestinal pharmacology, particularly with respect to diabetes
-Angiogenesis
-Cancer
-Cannabinoids as therapeutic agents
-Molecular pharmacology of vascular disease
-Modelling pharmacokinetics

Why choose this course?

-This is an intensive programme that will provide training in pharmacology, molecular biology and their application to drug discovery, using a problem based learning approach
-You will receive training in a range of pharmacological and molecular practical techniques as well as completing a research project
-Upon completion, you will be able to enter a successful career in the pharmaceutical industry or pursue further postgraduate research
-The School of Life and Medical Science will move into a brand new science building opening in September 2015 providing us with world class laboratories for our teaching and research. At a cost of £50M the new building provides spacious naturally lit laboratories and social spaces creating an environment that fosters multi-disciplinary learning and research

Careers

Graduates of the programme will be qualified for research and development positions in the pharmaceutical industries, to progress to a research degree or to consider regulatory, marketing or management roles in industry.

Teaching methods

Upon entering the programme, students are provided with introductory material to facilitate their transition to Master's level study. Cellular Molecular Biology is taught in parallel with Core Pharmacology, which both involve a high proportion of practical work. Students will experience a range of learning styles including conventional lectures, workshops and problem based learning. Teaching in Molecular Medicine and Pharmacovigilance & Drug Discovery Development uses case studies to foster skills such as working independently or as part of a team, demonstrating initiative and problem solving. You will also study a module in Biosciences Research Methods for Masters. All assessments are coursework only (including in-class tests), which are strategically phased throughout the course to provide regular feedback.

Structure

Modules
-Biosciences Research Methods for Masters
-Cellular Molecular Biology
-Core Pharmacology
-Drug Discovery Development and Pharmacovigilance
-Molecular Medicine
-Project-Mol Biology, Biotechnology, Pharmacology

Read less
The MSc in Cancer Research is aimed at life science and medical graduates who wish to specialise in the field of cancer research. Read more
The MSc in Cancer Research is aimed at life science and medical graduates who wish to specialise in the field of cancer research. The purpose of the programme is to provide students with extensive research-laboratory training and an overarching theoretical knowledge of cancer biology. The course has a unique, research-oriented approach with taught modules, resulting in an internationally recognised MSc degree. The obtained knowledge and skillset enables our graduates to pursue a career as a research-scientist in academia, in the medical field or in the biotechnology or pharmaceutical sector.

Specifically the course aims to:

1. Provide a broad and in-depth knowledge in molecular-, cellular- and clinical cancer biology.

2. Provide knowledge in a broad range of classic as well as state-of-the-art research technologies applied in cancer research.

3. Provide training in laboratory and research skills both at basic and advanced levels by assigning students a laboratory research project through which they will develop both technical competencies and critical thinking abilities.

4. Facilitate the interdisciplinary approach of cancer research by engaging clinical and nonclinical scientists, enabling the cross-fertilisation of ideas and thus promoting medically-focused research.

The MSc in Cancer research is a modular course, consisting of 30% taught material (equalling 25 ECTS units) combined with a strong, 70% research element (equal to 65 ECTS) allowing ample time for the students to gain in-depth research exposure.

The course material is delivered using a blended learning format (combination of face-to-face/traditional-format lectures, tutorials, self-directed learning and assignments) that will not only deliver the information the students have to attain, but also trains the students how to research independently and evaluate the information critically, which are key and valuable skills for a highly qualified cancer research scientist.

The research element will encompass two semesters. After an induction phase, the students will work on one research project throughout the two semesters allowing them to acquire a broad range of research skills ranging from state-of-the-art technologies through data interpretation to experimental design and data presentation. Available research project titles in participating laboratories of the School of Natural Sciences and other programme-associated Institutes will be provided to the students from which they can choose their project options. The students will write the MSc thesis on the findings of their research project..

Overall, the knowledge and laboratory experience providesour graduates with a great advantage when competing for either academic or industry-linked careers.

For further information please visit: http://www.nuigalway.ie/courses/research-postgraduate-programmes/structured-phd/cancer-research.html


How to apply:
Applications are made online via Postgraduate Applications Centre (http://www.pac.ie/nuigalway). The following documents must be supplied:
- A Curriculum Vitae
- A personal statement of approximately 600 words explaining why the the applicant wishes to undertake the Structured MSc in Cancer Research programme and how the programme fits into their career objectives.
Academic transcripts, unless the applicant is a graduate or current student of NUI Galway.

Read less
The MSc Pharmacology programme will give you a thorough understanding of the science of drugs and their effects on the human body. Read more
The MSc Pharmacology programme will give you a thorough understanding of the science of drugs and their effects on the human body.

You will gain an understanding of current techniques, develop laboratory ‘bench’ skills, as well as strong communication skills and the ability to think independently, in preparation for employment or PhD studies. A variety of learning and teaching methods such as lectures, seminars, practical laboratory classes and a laboratory-based research project are used.

A variety of career pathways are open to graduates of this programme. Research pharmacologists – work in laboratories in universities, government research institutes or in industry conducting experiments to investigate how the body works, understanding what goes wrong when a disease strikes and developing drugs and their targets to reverse or prevent the disease.

Pharmacology influences our everyday lives. Pills, potions, creams, inhalers and injections contain drugs that can prevent pain, indigestion, bacterial and viral infection, ease your breathing in asthma, inhibit and destroy cancer cells, and inhibit blood clots that cause strokes and heart attacks.

This Masters programme provides specialist training in the field of pharmacology enabling you to develop a comprehensive scientific understanding.

This programme has several different available start dates - for more information, please view the relevant web-page:
JANUARY 2017 - http://www.gcu.ac.uk/hls/study/courses/details/index.php/P01033-1FTAB-1617/Pharmacology_(Jan)?utm_source=XXXX&utm_medium=web&utm_campaign=courselisting

JANUARY 2018 - http://www.gcu.ac.uk/hls/study/courses/details/index.php/P01033-1FTAB-1718/Pharmacology?utm_source=XXXX&utm_medium=web&utm_campaign=courselisting

Employment Opportunities

A variety of career pathways are open to graduates of this programme.

Research pharmacologists – work in laboratories in universities, government research institutes or in industry conducting experiments to investigate how the body works, understanding what goes wrong when a disease strikes and developing drugs and their targets to reverse or prevent the disease.

Pharmacology teaching – as a pharmacologist your workplace could also be a university or college lecture theatre or laboratory teaching students a range subjects related to biology.

Clinical pharmacologists – once drugs have been developed in the laboratory clinical pharmacologists focus on the application of drugs for human use. Graduates with a pharmacology degree require further specialist training to become clinical pharmacologists.

Read less
Before any new therapy can be used, a thorough identification of its toxicity and safety is required. Therefore, drug toxicology and safety pharmacology are central to the chemical and pharmaceutical industries, and demand for 'pre-trained' employees is extremely high. Read more
Before any new therapy can be used, a thorough identification of its toxicity and safety is required. Therefore, drug toxicology and safety pharmacology are central to the chemical and pharmaceutical industries, and demand for 'pre-trained' employees is extremely high.

Hosted by the Institute of Cancer Therapeutics, the course addresses key aspects of preclinical drug evaluation through the study of drug discovery and development; safety pharmacology; mechanisms of drug-induced toxicities; regulatory affairs and bioanalytical sciences.

It will provide you with state-of-the-art training in the area of preclinical toxicology with an emphasis on the molecular and in vivo aspects of toxicological assessment.

It is designed for individuals with a first degree in a scientific disciple who want to specialise in new medicines development or undertake employment in the pharmaceutical industry.

Why Bradford?

-Includes seminars by scientists from regulatory agencies and pharmaceutical companies
-This course is designed to meet the demand of employers and provide you with a comprehensive overview of the drug safety discipline within the drug development process

Modules

-Critical Appraisal of a Current Topic in Safety Pharmacology
-Preclinical Models for Drug Evaluation
-Research and Analytical Methods in Pharmacology
-Toxicology and Safety Pharmacology
-Experimental Design
-Molecular Mechanisms of Toxicity
-Research Project (Safety Pharmacology)

Career support and prospects

The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.

Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.

Read less
If you’re an international fee-paying student you could be eligible for a £3,000 discount when you start your course in January 2017. Read more
If you’re an international fee-paying student you could be eligible for a £3,000 discount when you start your course in January 2017.
http://www.shu.ac.uk/VCAwardJanuary2017

This course increases your knowledge and skills in pharmacology and biotechnology to increase your competitiveness in the job market or complete research at PhD level. If you are already employed, this course can help you to further your career prospects.

The course is delivered by internationally recognised academics who are involved in biotechnology and pharmacology research. Research projects include studying the manipulation of proteins and their application to Alzheimer's disease, epilepsy, ion channels and the development of novel drugs from natural products.

You learn in detail how drugs act at the molecular and cellular level and then how biotechnological techniques are used to produce new drugs. Examples include developing new and effective treatments for diseases, such as Alzheimer’s and rheumatoid arthritis.
You also gain experience of the latest techniques used by the pharmaceutical industry to produce and study the effects of novel drugs.

The course gives you:
-Up-to-date knowledge of cellular and molecular pathology of various human diseases.
-The basis of therapeutic rationales for treating diseases and their development.
-An advanced understanding of recombinant DNA technology and how it is used to produce drugs.
-Experience of the latest practical techniques, such as cell culture, quantitative PCR analysis, cloning, western blotting, and analytical techniques such as HPLC and mass spectrometry.
-The transferable and research skills to enable you to continue developing your knowledge and improve your employment potential.

For more information, see the website: https://www.shu.ac.uk/study-here/find-a-course/mscpgdippgcert-pharmacology-and-biotechnology

Course structure

Full time – 14 months to Masters. Part time – typically 2 years to Masters. The certificate and diploma are shorter. Starts September and January.

The Masters (MSc) award is achieved by successfully completing 180 credits. The Postgraduate Certificate (PgCert) is achieved by successfully completing 60 credits. The Postgraduate Diploma (PgDip) is achieved by successfully completing 120 credits.

Core modules
-Cell biology (15 credits)
-Fundamentals of pharmacology (15 credits)
-Molecular biology (15 credits)
-Biotechnology (15 credits)
-Professional development (15 credits)
-New approaches to pharmacology (15 credits)
-Research methods and statistics (15 credits)
-Research project (60 credits)

Optional modules (one from)
-Applied biomedical techniques (15 credits)
-Cellular and molecular basis of cancer (15 credits)
-Pharmaceutical drug development (15 credits)
-Human genomics and proteomics (15 credits)

Assessment
Assessment is mostly by written examination and coursework including problem solving exercises, case studies and input from practical laboratory work. Research project assessment includes a written report and viva voce.

Read less
Exciting new opportunities for chemical intervention in disease have emerged based on a greater understanding of the molecular aspects of disease progression. Read more
Exciting new opportunities for chemical intervention in disease have emerged based on a greater understanding of the molecular aspects of disease progression. Drug discovery combines the expertise of medicinal chemists required in translating the understanding of the molecular aspects of disease progression to the identification of suitable chemical entities, and the process of optimisation that ultimately leads to the discovery of new medicines.

This exciting course run by the Institute of Cancer Therapeutics is designed to provide students with a 'state-of-the-art' education in modern drug discovery, which meets the demand of employers in the pharmaceutical industry.

Opportunities to learn the latest innovations in drug discovery are provided, including computer-aided drug design and techniques in parallel synthesis, as well as electronic data management.

Why Bradford?

-The course provides an expert view of the use of recent knowledge and up- to-the minute specialised approaches to discover novel drugs to help fight disease and increase the quality of life for patients
-It benefits from the multidisciplinary team of researchers in the field of drug design, synthesis, screening, pharmacology and toxicology both at the University and through our extensive links with experts at other universities and industry
-Students on the course will also benefit from working in excellent research laboratories in a research focused environment

Modules

Core modules
-Critical Appraisal of a Current Topic in Drug Discovery
-Principles of Drug Discovery
-Research and Analytical Methods
-Research Project in Drug Discovery

Option modules
-Molecular Basis of Cancer and Cancer Therapy
-Toxicology and Safety Pharmacology
-Case Studies in Drug Discovery
-Chemical Toolbox for Drug Discovery
-Molecular Mechanisms of Toxicity

Career support and prospects

The University is committed to helping students develop and enhance employability and this is an integral part of many programmes. Specialist support is available throughout the course from Career and Employability Services including help to find part-time work while studying, placements, vacation work and graduate vacancies. Students are encouraged to access this support at an early stage and to use the extensive resources on the Careers website.

Discussing options with specialist advisers helps to clarify plans through exploring options and refining skills of job-hunting. In most of our programmes there is direct input by Career Development Advisers into the curriculum or through specially arranged workshops.

Many students go on to study for PhDs either at Bradford or elsewhere. Recent graduates are studying at Dundee, Newcastle and Glasgow universities. Those in employment are in R&D and clinical research roles.

Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer.

This will be underpinned by a thorough knowledge of cancer biology and pathology and research methodologies.

This knowledge will provide an excellent grounding in the development, use and evaluation of cancer therapies, which will enhance career prospects in many areas of early phase clinical trials and clinical drug development in the cancer setting.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Molecular Diagnostic & Therapeutics
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Genomic Approaches to Human Diseases
• Paediatric & Adolescent Oncology
• Pathology of Cancer

Core Module for MSc

• Dissertation.

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

Find out more about the BCI at http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research. Read more
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research.

You will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.

You will gain a thorough knowledge of research methodologies and laboratory techniques, which you will fully utilise in the laboratory research project stage. The valuable research experience you will gain from working with leading cancer experts, will give you a solid foundation upon which a future career in scientific research can be built.

Compulsory Modules

• Biological Therapies
• Cancer Biology
• Cancer Pharmacology
• Drug Development
• Genomic Approaches to Human Diseases
• Molecular Diagnostic & Therapeutics
• Pathology of Cancer
• Research Lab Skills
• Research Methods

Elective Modules

• Cancer Prevention & Screening
• Paediatric & Adolescent Oncology

Core Module for MSc

• Lab project


Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments.

This will be underpinned by a thorough knowledge of cancer biology and pathology, drug development and research methodologies.

This knowledge will provide you with a good grounding in oncology within a clinical setting which will enhance prospects for those wanting to pursue a clinical academic career.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Genomic Approaches to Human Diseases
• Imaging
• Paediatric & Adolescent Oncology
• Pathology of Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Biological Therapies
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer

Core Module for MSc

• Dissertation

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, all our programmes are taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Read more
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Whilst these treatment have served well and new drugs will continue to be designed, clinical trials over the last five years have shown that boosting the body’s immune system, whose main task is to deal with invading pathogens, can help our immune system to destroy tumour cells. Many of the new immunotherapies may be tested in combination with more conventional treatments or tested alone, but investigators and oncologists now believe immunotherapy, initially combined with pharmacological treatments, will soon provide curative therapies and certainly give many patients a new lease of life.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of the Cancer Immunotherapy MSc are to:
-Provide an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data
-Deliver a programme of advanced study to equip students for a future career in anti-cancer drug and immunotherapy development
-Cover new areas in immunotherapy (some of which may enhance existing pharmacological therapies including: History of immunotherapy and review of immune system; Monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; Adoptive T cell therapy; Dendritic cell vaccines; Antibodies that stimulate immunity; Adjuvant development for vaccines; Epigenetics and cancer: improving immunotherapy; Immuno-chemotherapy: integration of therapies; Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis; Dendritic cell vaccine development and Pox virus cancer vaccine vectors; Microbial causes of cancer and vaccination

Students will have access to highly qualified researchers and teachers in pharmacology and immunology, including those at the Cellular and Molecular Immunology Research Centre. Skills gained from research projects are therefore likely to be highly marketable in industry, academia and in the NHS. Students will be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Advanced Immunology (core, 20 credits)
-Cancer Immunotherapy (core, 20 credits)
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)

After the course

Students will have many opportunities to work in industry. There are established industries working hard to develop cancer immunotherapies including Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an innumerate number of start-up companies appearing including Omnis Pharma, UNUM Therapeutics and Alpine Immune Sciences.

Students will also have ample opportunity for future postgraduate study either within the School of Human Sciences and the Cellular and Molecular Immunology Centre at the MPhil/PhD level or beyond, even with some of our research partners within the UK, Europe and beyond.

Read less
Upon graduation from the Master’s Programme in Translational Medicine (TRANSMED) you can be expected to. -Be fluent in medical sciences and clinical practice from the point of view of a researcher. Read more
Upon graduation from the Master’s Programme in Translational Medicine (TRANSMED) you can be expected to:
-Be fluent in medical sciences and clinical practice from the point of view of a researcher.
-Be familiar with up-to-date translational research methodologies.
-Be adept at scientific reasoning and critical analysis of scientific literature.
-Acknowledge the regulatory and ethical aspects of biomedical and clinical research.
-Have mastered scientific and medical terminologies.
-Have excellent communication and interpersonal skills, enabling you to find employment in an international and interdisciplinary professional setting.

The University of Helsinki will introduce annual tuition fees to foreign-language Master’s programmes starting on August 1, 2017 or later. The fee ranges from 13 000-18 000 euros. Citizens of non-EU/EEA countries, who do not have a permanent residence status in the area, are liable to these fees. You can check this FAQ at the Studyinfo website whether or not you are required to pay tuition fees: https://studyinfo.fi/wp2/en/higher-education/higher-education-institutions-will-introduce-tuition-fees-in-autumn-2017/am-i-required-to-pay-tuition-fees/

Programme Contents

The TRANSMED studies are built upon three core educational themes:
Development of Research Skills
These include an introduction to current methodologies, which are further developed during a training period in a research group; research ethics: principles of clinical investigation; and writing of research or grant proposals.

Studies in Human Disease
These range from normal human physiology and anatomy, and basic biomedical courses, to more specialised studies covering various topics pertinent to the specialist option. You supplement these studies with clinical rounds, during which you have an opportunity to study selected patient cases in hospital wards, under the supervision of a clinician mentor.

Development of Communication Skills
These are promoted throughout the curriculum, through utilisation of interactive approaches and discussions, problem-based learning and oral presentations. The multidisciplinary TRANSMED community encompasses a wide range of educational backgrounds and provides ample opportunities for direct interactions with medical students, science and clinical teachers to enable you to practice and adopt interdisciplinary communication skills. At the end of the course of study, your communication skills will be evaluated in the final exam, during which you will orally present your research plan to expert examiners.

Selection of the Majors

The major of the programme is Translational medicine. During your first study year you can choose any of the five available specialisation options. These options and their specific goals are:
Neuroscience and Psychobiology
-To acquire knowledge on research methodology and state-of-the-art information in systems and cognitive neuroscience, as well as in clinical neuropsychology.
-To learn to produce new scientific information in the fields of psychobiology of human life, health, and stress, and to transfer the results between basic research and clinical settings.

Cancer
-To acquire basic knowledge of the principles of neoplastic growth, cancer progression and dissemination.
-To acquire basic understanding of the interplay between different cell types during neoplastic growth.
-To acquire knowledge of major research methodologies and disease models in cancer biology.

Regenerative Medicine
-To understand the principles of developmental and stem cell biology and regenerative pharmacology as the basis of regenerative therapies.
-To be familiar with the major technologies applied in regenerative medicine, including tissue engineering, cell and organ transplantation and transplantation immunology.
-To understand the ethical principles of clinical translation of basic research and application of regenerative medicine therapies.

Metabolic Disorders
-To be able to understand the basic metabolic pathways.
-To understand the pathophysiology of metabolic disorders such as diabetes mellitus, insulin resistance, metabolic syndrome and obesity.
-To be able to use genetic knowledge as a basis for prediction, diagnosis and treatment of metabolic disorders.

Cross-Disciplinary Translational Medicine
-To achieve a broad understanding of topics and methods in the field of Translational medicine.

Programme Structure

The scope of the programme is 120 credits (ECTS) and can be completed within two academic years (60 ECTS / year).

The Master of Science in Translational medicine degree includes 60 ECTS of advanced and 60 ECTS of other studies. Both of these include both obligatory and optional studies.

The majority of the advanced studies are related to the chosen specialist option and include:
-Master’s thesis (30 ECTS)
-Placement in a research group for learning advanced methods in your selected field of study
-Methodological and human health and disease-related courses
-Clinical rounds in Helsinki University Central Hospital (HUCH) clinics
-Final examination in your field of specialisation

The other studies include e.g.
-Article analysis, scientific writing and presentation
-Biomedicine and introductory courses in research methods
-Career planning and orientation
-Individual study coaching and personal study plans
-Research ethics

You can select the optional courses based on your personal interests, or to support your chosen specialisation option. You can also include courses from other suitable Master’s programmes at the University of Helsinki, such as:
-Life Science Informatics
-Genetics and molecular biosciences
-Neuroscience
-Human Nutrition and Food Behaviour

You can also include studies in other universities under the flexible study right-agreement (JOO).

Career Prospects

The Master of Science in Translational medicine degree provides excellent opportunities to apply for and attend postgraduate studies. Currently, 50% of TRANSMED graduates are continuing their studies in doctoral programmes, either at the University of Helsinki or abroad.

TRANSMED graduates are also highly valued in the private sector. Around 35% of graduates have been employed directly by bioindustry, pharma or other health sector enterprises either in Finland or abroad. Titles include product manager, product specialist, personalised health care manager etc. All such enterprises usually recruit both at the graduate (MSc) and postgraduate (PhD) levels.

The health and health technology sectors represent a rapidly emerging field, and one of the areas with a growing importance as the population ages and the costs of new therapies steadily increase. Thus, the demand for well-trained specialists in the field of translational medicine is likely to increase in the near future, providing excellent career prospects globally.

Internationalization

The Translational Medicine major is only available in this international programme, making the programme attractive to both Finnish and international students. Indeed, opportunities for personal interaction with students from different cultures are an integral feature of the studies. During your studies, you can also volunteer to act as a tutor for the incoming international students.

The international research community in The Academic Medical Centre Helsinki actively participates in teaching in TRANSMED. You complete the research group practice for your Master’s thesis in multicultural research groups.

It is also possible to complete your Master’s thesis work or research group placement abroad, or to include coursework done at a foreign university.

Research Focus

The specialisation options of the programme – Neuroscience and psychobiology, Cancer, Regenerative medicine, Metabolic disorders, and Cross-disciplinary translational medicine – are closely aligned with the research focus areas of the Faculty of Medicine: malignancy, inflammation, metabolism, degenerative processes as well as psychiatric disorders and their mechanisms. You therefore have an opportunity to learn from, and be supervised by, the leading experts and professors in their fields.

Read less
The Graduate Program in Pharmaceutical Sciences, located on the Texas Tech University Health Sciences Center (TTUHSC) campus at Amarillo, Texas offers Masters (M.S.) and Doctoral (Ph.D.) degrees in integrated biomedical/pharmaceutical research as part of the TTUHSC Graduate School of Biomedical Sciences. Read more
The Graduate Program in Pharmaceutical Sciences, located on the Texas Tech University Health Sciences Center (TTUHSC) campus at Amarillo, Texas offers Masters (M.S.) and Doctoral (Ph.D.) degrees in integrated biomedical/pharmaceutical research as part of the TTUHSC Graduate School of Biomedical Sciences.

About the Program

Modern pharmaceutical science encompasses a number of disciplines, including biochemistry, molecular biology, physiology, immunology, pharmacology, pharmaceutics, and medicinal chemistry. The field is unified by the search for novel drug targets and the development of new agents and formulations for the treatment biomedical disease. This includes cutting edge techniques to target drugs to sites of therapeutic action and to reduce adverse effects related to drug metabolism, lack of target selectivity, and pharmacogenetic differences within the human population. PhD’s in pharmaceutical science are well trained for drug discovery and development positions in academic labs, government (e.g., Food and Drug Administration), and the pharmaceutical or biotech industries.
Each student completes a core curriculum including foundation training in biochemistry, physiology, pharmacology and pharmaceutics designed to give students a basic understanding of the biomedical processes by which the body operates and the pharmaceutical agents and delivery systems available to interact with these systems. Electives studies offer the student the opportunity for specialization in more focused areas of interest, including receptor biology, molecular drug action, cell signaling, cancer research, pharmacokinetics, drug metabolism, and biotechnology. Communication, research design, professional skills and ethics are developed throughout the curriculum in complementary courses. Students become immersed in the philosophy of life-long learning and the importance of maintaining and updating their knowledge base as critical, independent thinkers and scientists. The faculty sees this integrated approach as one of the primary strengths of the program, combining cutting-edge molecular and biomedical breakthroughs with modern drug development, targeting and formulation. A broad range of biomedical and pharmaceutical research opportunities are available throughout the department. Focus areas of the Department with links to specific faculty interests are listed below:
Aging/Brain/Neuroprotection/Stroke
Blood Brain Barrier and Neurovascular
Cancer and Molecular Biology & Therapy
Cardiovascular Disease & Regulation
Drug Discovery and Formulation & Pharmacokinetics
Receptor Biology, Cell Signaling & Immunotherapy

Funding

Typically, students may complete a course of study for a Ph.D. degree within 4-5 years or a Masters degree in about half that time (2-2.5 years). Funding is available in the form of stipends ($23,000) from the Department/Graduate School and from individual faculty research resources. These stipends are awarded on a competitive basis to qualifying Ph.D. candidates. Currently, the Department has 43 funded graduate students.

Read less
The MRes in Biomedical Research offers advanced research training in a broad range of laboratory based medical science. The emphasis of the course is how to do successful research and the research area is decided by the student. Read more
The MRes in Biomedical Research offers advanced research training in a broad range of laboratory based medical science. The emphasis of the course is how to do successful research and the research area is decided by the student. Participating departments include Biomolecular Medicine, Molecular Medicine, Cancer Medicine, Reproductive and Developmental Biology, Anaesthetics, Pain Medicine and Intensive Care, Biosurgery and Surgical Technology, Leukocyte Biology and Cardiovascular Sciences.

The research interests of the participating departments cover many aspects of molecular, cellular and physiological science including Bacterial virulence, Biomarkers of disease, Bioinformatics, Carcinogenesis, Cancer Biology, Cell Biology, Cell Signalling, Chemokines and their receptors, DNA damage and Repair, Electrophysiology, Immunosuppression, Leukocyte biology, Live cell imaging, Metabolomics/Metabonomics, Microbial Pathogenesis, Molecular Genetics, Molecular Motors, Molecular Pharmacology, Molecular Toxicology, Muscle Physiology, and Vascular Development, Neurological receptors, Nuclear receptors, Sepsis, Single molecule microscopy, Stem Cell Biology.

Students complete two research projects of their own choosing and through a core programme learn how to collect, analyse and interpret scientific research findings. They learn how to prepare data for publication, how to present and defend research data at scientific meetings and how to put together a grant application. The core programme also introduces students to advanced research techniques through a series of workshops and offers students a wide range of transferable skills courses. In addition to the core programme, the course comprises of other streams that offer further opportunities in specific areas. The course is an excellent grounding for students wishing to pursue a career in research and about 90% of past graduates have progressed to the PhD degree.

Please visit the course website for more information about how to apply, and for more information about the streams of specialism which run within the course.

Read less

Show 10 15 30 per page


Share this page:

Cookie Policy    X